At the heart of the exchange is a question that sounds simple but is anything but: when a device on your wrist reports that you slept six hours and twelve minutes, how much of that number should we believe? Actigraphy, the technique in question, infers sleep from movement. The underlying logic is straightforward—people move less when they are asleep—so algorithms classify each epoch of recorded activity as sleep or wake based on how much motion the accelerometer detects. Modern research-grade devices sample acceleration many times per second and apply validated scoring rules to translate that raw signal into sleep onset, sleep offset, and total sleep time. The approach has become the workhorse of ambulatory sleep research precisely because it can collect data for days or weeks in people’s own homes, something the gold standard of polysomnography, with its electrodes, wires, and laboratory bedrooms, simply cannot do at scale.

But the convenience of actigraphy comes with well-documented trade-offs. Validation studies comparing wrist actigraphy against polysomnography have repeatedly shown that the technique performs well at identifying when people are asleep overall, yet it systematically misclassifies quiet wakefulness as sleep. A person lying still in bed, awake but motionless, looks identical to a sleeping person through the lens of a movement sensor. The practical consequence is that actigraphy tends to overestimate total sleep time relative to polysomnography, and the discrepancy widens in people with fragmented or disturbed sleep, such as patients with insomnia. The American Academy of Sleep Medicine’s systematic review and meta-analysis of actigraphy, cited in the exchange, codified these performance characteristics and remains the reference point for how clinicians and researchers should interpret actigraphic data. Any study that uses actigraphy to make claims about sleep duration must therefore contend with the possibility that some of what it calls sleep is actually stillness.

The second axis of the debate concerns statistics rather than sensors. Khan and Riaz raised concerns about how the original study handled covariates in its regression models, and Baron and Landvatter’s reply engages directly with that critique by invoking a well-known epidemiological pitfall sometimes called the table 2 fallacy. The term, coined by statisticians Daniel Westreich and Sander Greenland, describes a common mistake in which coefficients for confounder variables displayed alongside the main exposure effect in a regression table are interpreted as if they carried the same causal meaning as the exposure itself. In a model estimating how short sleep relates to some health outcome while adjusting for age, sex, and body mass index, the coefficient for body mass index is not necessarily an estimate of the causal effect of body mass index—it is in the model to soak up confounding, and its interpretation depends on assumptions the authors may never have intended to defend.

Related guidance from clinical psychopharmacology researcher Chittaranjan Andrade, also cited in the reply, walks clinicians through what covariates and confounders actually do in adjusted analyses: they change the contrast being estimated. When you add a covariate to a regression, the coefficient on your variable of interest now represents the association at a fixed level of that covariate, holding everything else constant. Whether that adjustment clarifies or distorts the relationship depends on whether the covariate is a true confounder, a mediator on the causal pathway, a collider, or a precision variable. Adjusting for a mediator can erase a real effect; adjusting for a collider can manufacture a spurious one. The reply’s decision to anchor its defense in this literature signals that the authors view the critique as fundamentally a dispute over causal inference conventions rather than over the raw data itself.

Why does this matter beyond the walls of academic sleep medicine? Because actigraphic sleep duration is increasingly treated as a modifiable risk factor, and public health messaging built on observational associations can shift clinical practice and consumer behavior. If a study finds that people whose trackers say they sleep less than seven hours show worse outcomes on some measure, the strength of that finding depends on both the accuracy of the measurement and the integrity of the statistical adjustment. Overestimated sleep duration in a subset of participants could attenuate a true association; mis-specified covariate adjustment could exaggerate or reverse one. The exchange between the Utah team and their critics is thus a compact case study in how the field polices itself, with letters, replies, and methodological citations serving as the peer-review system’s ongoing correction mechanism after initial publication.

The original Baron study deserves attention in its own right for the population it targeted. People who self-report sleeping less than seven hours are a heterogeneous group: some are genuinely short sleepers with objectively verified restricted sleep, while others spend adequate time in bed but sleep poorly, and still others are natural short sleepers who function well on less sleep than average. Prior comparative work, including the community-sample study by Matthews and colleagues cited in the reply, has shown that self-reported habitual sleep, sleep diary estimates, actigraphy, and polysomnography can diverge substantially within the same individuals, with self-report and objective measures sometimes differing by more than an hour. Studying the gap between perceived short sleep and device-measured short sleep is therefore not a niche exercise—it speaks directly to whether subjective complaints of insufficient sleep should trigger the same clinical workup as objectively confirmed sleep restriction.

The technological landscape is also shifting beneath this debate. A 2024 review in Sleep Health compared EEG-based consumer devices, iteratively improved low-cost multisensor trackers, and actigraphy-only devices, reflecting a market in which millions of people now wear sleep trackers daily and researchers increasingly mine that data. Consumer wearables add heart rate, movement, and sometimes temperature signals, and some incorporate limited electroencephalography, promising better discrimination between sleep and quiet wake than movement alone. Yet the validation standards for consumer devices lag behind those for clinical actigraphy, and accuracy can vary across sleep stages, age groups, and clinical populations. The methodological questions raised in this journal exchange—how to score sleep, how to adjust for confounding, how to interpret adjusted coefficients—apply with equal force to the flood of wearable data now shaping popular beliefs about sleep hygiene.

Funding for the underlying research came from the National Heart, Lung, and Blood Institute and the National Center for Advancing Translational Sciences, and the authors report no competing interests. The reply, accepted in June 2026 and published in August as volume 22, article 136 of the journal, is deliberately narrow: it does not claim to resolve the measurement problem, only to clarify what the original analysis did and did not assert. That restraint is itself informative. In a field where sleep duration is routinely framed as a pillar of health alongside diet and exercise, the most rigorous researchers are increasingly explicit that a wrist-worn estimate processed through a regression model is a statistical construct with documented error structure, not a direct readout of biological sleep. Readers interpreting their own tracker data, and clinicians interpreting actigraphic reports, would do well to keep both the sensor’s blind spots and the statistician’s caveats in mind.

What emerges from the exchange is a portrait of a maturing discipline wrestling with its instruments. Actigraphy earned its place in sleep medicine by making large-scale, real-world sleep measurement feasible, and the American Academy of Sleep Medicine’s GRADE-assessed review confirms its clinical utility for evaluating sleep disorders and circadian rhythm disturbances. At the same time, the technique’s known biases and the subtleties of adjusted regression analyses mean that every actigraphic finding carries an error bar that is methodological as much as statistical. The Baron team’s defense, and the critique that provoked it, illustrate how scientific knowledge advances not only through new discoveries but through adversarial scrutiny of existing ones. For a public increasingly obsessed with quantifying its own sleep, the lesson is clear: the number on your wrist is a model’s opinion, and the studies built on such numbers are only as strong as the assumptions buried in their tables.

Subject of Research: Methodological debate over actigraphic measurement of sleep duration and covariate adjustment in sleep research

Article Title: Reply to “Limitations in study of actigraphic estimates of sleep”

Article References: Baron, K. G., & Landvatter, J. (2026). Reply to “Limitations in study of actigraphic estimates of sleep”. Journal of Clinical Sleep Medicine, 22(1), Article 136. https://doi.org/10.1007/s44470-026-00136-1

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00136-1

Keywords: actigraphy, sleep duration, polysomnography, sleep trackers, table 2 fallacy, confounding, regression analysis, sleep medicine, wearable devices, sleep measurement, Journal of Clinical Sleep Medicine, methodology